Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
In a recent settlement, the state agreed to expand coverage of HCV treatment—but only to those with advanced liver scarring.
The state is appealing a ruling that requires the prison system to properly treat inmates with the virus.
But doing so would place a considerable financial burden on prison budgets.
The subscription-based model is the first of its kind.
The right was secured via a class-action lawsuit settlement.
Advocates say out of some 3,000 inmates recently diagnosed with the virus, just 46 have received any sort of treatment.
Three lawsuits allege prison officials denied them treatment for more than a year, despite serious illness.
Lawsuits across the country are demanding access to treatment for incarcerated populations. Here’s why.
Existing federal law could permit prisons to negotiate a 90 percent–plus discount—without scaring off pharma.
Louisiana health officials are adopting the country’s first subscription model for hep C cures.
Researchers analyzed data resulting from a uniform hepatitis C testing policy in Washington state’s correctional facilities.
A new report shows people who inject drugs are substantially more likely to contract HIV or HCV post-incarceration.
Thus far, no state prison systems have adopted the protocols that advocates are demanding.
New recommendations in the Annals of Internal Medicine would increase access to treatment.
The settlement ensures all affected state prisoners will be treated for the disease.
The idea is being referred to as a “subscription-based” model.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.